AKI and Delirium Risk Prediction and Cost Burden Study
Public ClinicalTrials.gov record NCT07866560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Hospital-Acquired Acute Kidney Injury and Delirium Risk Prediction and Cost Burden
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this study is to learn how to better predict two common health problems that can happen during a hospital stay: acute kidney injury (AKI) and delirium. AKI is a sudden decline in kidney function. Delirium is a sudden change in thinking or awareness that can cause confusion. Both conditions can make people stay in the hospital longer and may increase health care costs. The two main questions this study aims to answer are: 1. How do hospital acquired AKI and delirium affect how long people stay in the hospital and the cost of their care? 2. Can early information from a patient's electronic health record help researchers predict who may develop AKI or delirium during a hospital stay? Researchers will review information already collected in the electronic health records of adults who were admitted to the hospital. They will look at details such as age, health conditions, laboratory results, nursing and ancillary flowsheets, medications, and vital signs recorded during the first day of hospitalization. Researchers will use this information to build a computer model that estimates a patient's risk of developing AKI or delirium later during the hospital stay. They will also study how these complications affect the length of the hospital stay and the cost of care. This study will not change the care patients receive. Researchers will only use existing medical record data. The results may help doctors identify patients at higher risk earlier and guide steps that may prevent these complications in the future.
Study identification
- NCT ID
- NCT07866560
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 25,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2026 (Actual)
- Primary completion
- Apr 28, 2027 (Estimated)
- Completion
- Sep 28, 2027 (Estimated)
- Last update posted
- Oct 8, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07866560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2026 · Synced Oct 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07866560 live on ClinicalTrials.gov.